Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
DRUGSTORE COM INC (DSCM)
|
Add to portfolio |
|
|
|
| Price: |
$3.77
| | Metrics |
| OS: |
106.9
|
M
| |
-6
|
% ROE
|
| Market cap: |
$403
|
M
| |
-5
|
% ROIC
|
|
Net cash:
|
$18.5
|
M
| |
$0.17
|
per share
|
|
EV:
|
$384
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$7.3
|
M
| |
52.6
|
x EV/EBITDA
|
|
EBIT
|
($6.8)
|
M
| |
|
|
| EPS |
($0.07)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jan-02-11 | Jan-03-10 | Dec-28-08 | Dec-30-07 | Dec-31-06 | Jan-01-06 | Jan-02-05 | Dec-28-03 |
| Revenues | 456.5 | 375.6 | 322.2 | 339.3 | 315.1 | 399.4 | 360.1 | 245.7 |
| Revenue growth | 21.5% | 16.6% | -5.0% | 7.7% | -21.1% | 10.9% | 46.5% | 26.7% |
| Cost of goods sold | 322.0 | 263.4 | 227.5 | 248.3 | 236.4 | 317.4 | 286.9 | 195.5 |
| Gross profit | 134.5 | 112.2 | 94.7 | 91.0 | 78.7 | 82.1 | 73.2 | 50.2 |
| Gross margin | 29.5% | 29.9% | 29.4% | 26.8% | 25.0% | 20.5% | 20.3% | 20.4% |
| Sales and marketing | 46.6 | 37.7 | 32.5 | 30.1 | 27.4 | 32.8 | 24.6 | 17.5 |
| Research and development | 27.3 | 24.9 | 23.0 | 18.3 | 16.2 | 12.8 | 9.6 | 8.3 |
| General and administrative | 20.2 | 17.6 | 19.9 | 20.9 | 15.4 | 15.8 | 17.1 | 11.1 |
| EBITA | -8.7 | -9.4 | -18.7 | -18.1 | -17.3 | -19.2 | -17.7 | -17.5 |
| EBITA margin | -1.9% | -2.5% | -5.8% | -5.3% | -5.5% | -4.8% | -4.9% | -7.1% |
| Amortization of intangibles | 0.4 | 0.5 | 0.9 | 1.2 | 2.1 | 3.0 | 4.0 | 1.7 |
| EBIT | -9.2 | -9.9 | -19.5 | -19.3 | -19.3 | -22.2 | -21.6 | -19.3 |
| EBIT margin | -2.0% | -2.6% | -6.1% | -5.7% | -6.1% | -5.6% | -6.0% | -7.8% |
| Pre-tax income | -9.6 | -9.9 | -18.9 | -11.5 | -13.0 | -20.9 | -48.7 | -18.6 |
| Income taxes | -6.1 | -8.5 | -10.6 | 0.0 | 0.0 | 0.0 | -1.0 | 0.0 |
| Tax rate | 63.1% | 86.0% | 56.2% | 0.0% | 0.0% | 0.0% | 2.0% | 0.0% |
| Earnings from continuing ops | -3.6 | -1.4 | -8.3 | | | | | |
| Earnings from discontinued ops | 6.1 | 8.5 | 10.6 | 6.1 | 4.6 | | | |
| Net income | -3.6 | -1.4 | -8.3 | -11.5 | -13.0 | -20.9 | -47.7 | -18.6 |
| Net margin | -0.8% | -0.4% | -2.6% | -3.4% | -4.1% | -5.2% | -13.3% | -7.6% |
| |
| Diluted EPS | ($0.03) | ($0.01) | ($0.09) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares outstanding (diluted) | 102.2 | 97.0 | 96.5 | 95.4 | 93.4 | 90.8 | 76.7 | 69.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|